Call for CQ volunteers to trial COVID-19 vaccine
CALLS for Queensland residents to take part in human trials come as a state-developed COVID-19 vaccine nears completion.
Trials will take place for 100 volunteers in July following a fast-tracked development which saw Queensland government inject a $10 million boost into the efforts.
Innovation Minister Kate Jones announced the trial news today, labelling the development a "major milestone" for Queensland pharmaceuticals as phase one of clinical tests edges closer.
She said the vaccine had received the backing of global pharmaceuticals giant CSL Ltd.
CSL announced it had signed an agreement with major funding backer the Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Queensland to manufacture Queensland's vaccine immediately.
Ms Jones said the vaccine was now only one of five worldwide to have signed a global manufacturing deal with CEPI.
"That means our vaccine is one of the most promising in the world. This has the potential to save thousands of lives not only in Queensland but across the globe"
A spokeswoman for UQ University confirmed phase one of the study will focus on the vaccine's safety with its side effects and ability to create antibodies closely monitored.
Volunteers are not required to be infected with the virus, nor will they be exposed to it during the trial.
The second phase will reportedly involve 800-1000 volunteers and would likely take place where a group of infections are present.
Ms Jones said the latest development would undoubtedly provide a huge boost to Queensland's entire pharmaceuticals industry.
"We also have the capacity to conduct clinical trials on life-saving new vaccines," she said.
"This will help us tap into a multi-trillion-dollar industry and create more jobs for Queenslanders in the future.
"CSL will manufacture the vaccine for phase 2 and 3 clinical trials, involving larger groups of volunteers, and if all goes well, they will also manufacture the final vaccine for Australian and global demand.
"Regardless of whether this vaccine is successful, today's announcement proves that we have some of the world's best medical researchers."